Interim 2023/24 season influenza vaccine effectiveness in primary and secondary care in the United Kingdom
We report 2023/24 season interim influenza vaccine effectiveness for three studies, including primary care in Great Britain, hospital settings in Scotland and hospital settings in England. Adjusted vaccine effectiveness against all influenzas ranged from 63% (46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 28. Feb. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Whitaker, Heather [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2024.02.27.24303426 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI042663431 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI042663431 | ||
| 003 | DE-627 | ||
| 005 | 20240229090744.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2024.02.27.24303426 |2 doi | |
| 035 | |a (DE-627)XBI042663431 | ||
| 035 | |a (biorXiv)10.1101/2024.02.27.24303426 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Whitaker, Heather |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interim 2023/24 season influenza vaccine effectiveness in primary and secondary care in the United Kingdom |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a We report 2023/24 season interim influenza vaccine effectiveness for three studies, including primary care in Great Britain, hospital settings in Scotland and hospital settings in England. Adjusted vaccine effectiveness against all influenzas ranged from 63% (46 to 75%) to 65% (41 to 79%) among children aged 2-17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18-64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Findlay, Beth |4 aut | |
| 700 | 1 | |a Zitha, Jana |4 aut | |
| 700 | 1 | |a Goudie, Rosalind |4 aut | |
| 700 | 1 | |a Hassell, Katie |4 aut | |
| 700 | 1 | |a Evans, Josie |4 aut | |
| 700 | 1 | |a Kalapotharakou, Panoraia |4 aut | |
| 700 | 1 | |a Agrawal, Utkarsh |4 aut | |
| 700 | 1 | |a Kele, Beatrix |4 aut | |
| 700 | 1 | |a Hamilton, Mark |4 aut | |
| 700 | 1 | |a Moore, Catherine |4 aut | |
| 700 | 1 | |a Byford, Rachel |4 aut | |
| 700 | 1 | |a Stowe, Julia |4 aut | |
| 700 | 1 | |a Robertson, Chris |4 aut | |
| 700 | 1 | |a Couzens, Anastazia |4 aut | |
| 700 | 1 | |a Jamie, Gavin |4 aut | |
| 700 | 1 | |a Hoschler, Katja |4 aut | |
| 700 | 1 | |a Pheasant, Kathleen |4 aut | |
| 700 | 1 | |a Button, Elizabeth |4 aut | |
| 700 | 1 | |a Quinot, Catherine |4 aut | |
| 700 | 1 | |a Jones, Tim |4 aut | |
| 700 | 1 | |a Anand, Sneha |4 aut | |
| 700 | 1 | |a Watson, Conall |4 aut | |
| 700 | 1 | |a Andrews, Nick |4 aut | |
| 700 | 1 | |a de Lusignan, Simon |4 aut | |
| 700 | 1 | |a Zambon, Maria |4 aut | |
| 700 | 1 | |a Williams, Christopher |4 aut | |
| 700 | 1 | |a Cottrell, Simon |4 aut | |
| 700 | 1 | |a Marsh, Kimberly |4 aut | |
| 700 | 1 | |a McMenamin, Jim |4 aut | |
| 700 | 1 | |a Lopez-Bernal, Jamie |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 28. Feb. |
| 773 | 1 | 8 | |g year:2024 |g day:28 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.02.27.24303426 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 28 |c 02 | ||